4//SEC Filing
Li Zhilin 4
Accession 0001213900-21-001170
CIK 0001106644other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:05 PM ET
Size
5.3 KB
Accession
0001213900-21-001170
Insider Transaction Report
Form 4
Li Zhilin
DirectorCEO & Interim CFO10% Owner
Transactions
- Award
Common Stock
2020-12-23+2,000,000→ 12,050,000 total
Footnotes (1)
- [F1]On December 23, 2020, the reporting person was granted 2,000,000 shares of Issuer's common stock under the Issuer's 2010 Long-Term Incentive Plan, vesting immediately with no restrictions, as partial offset of her accrued but unpaid cash compensation by serving as the Issuer's Chairman of the Board, Chief Executive Officer and interim Chief Financial Officer.
Documents
Issuer
CHINA PHARMA HOLDINGS, INC.
CIK 0001106644
Entity typeother
Related Parties
1- filerCIK 0001342188
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:05 PM ET
- Size
- 5.3 KB